Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;12(9):1338-44.
doi: 10.3201/eid1209.060122.

Lymph node biopsy specimens and diagnosis of cat-scratch disease

Affiliations

Lymph node biopsy specimens and diagnosis of cat-scratch disease

Jean-Marc Rolain et al. Emerg Infect Dis. 2006 Sep.

Abstract

We report microbiologic analysis of 786 lymph node biopsy specimens from patients with suspected cat-scratch disease (CSD). The specimens were examined by standard, cell culture, and molecular methods. Infectious agents were found in samples from 391 (49.7%) of 786 patients. The most commonly identified infectious agent was Bartonella henselae (245 patients, 31.2%), the agent of CSD. Mycobacteriosis was diagnosed in 54 patients (6.9%) by culture and retrospectively confirmed by using a specific real-time PCR assay. Neoplasm was diagnosed in 181 specimens suitable for histologic analysis (26.0%) from 47 patients. Moreover, 13 patients with confirmed Bartonella infections had concurrent mycobacteriosis (10 cases) or neoplasm (3 cases). A diagnosis of CSD does not eliminate a diagnosis of mycobacteriosis or neoplasm. Histologic analysis of lymph node biopsy specimens should be routinely performed because some patients might have a concurrent malignant disease or mycobacteriosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution of patients by age and group. Cat-scratch disease (CSD) group, patients with Bartonella-positive PCR results in lymph node samples; Non-CSD group, patients with Bartonella-negative PCR results. For patients <25 years of age, p = 0.032 for CSD group versus non-CSD group.
Figure 2
Figure 2
Detection of Bartonella henselae in the lymph node of a patient with cat-scratch disease and tuberculosis by direct immunofluorescent assay with a monoclonal antibody (magnification ×400).

References

    1. Ridder GJ, Boedeker CC, Technau-Ihling K, Grunow R, Sander A. Role of cat-scratch disease in lymphadenopathy in the head and neck. Clin Infect Dis. 2002;35:643–9. 10.1086/342058 - DOI - PubMed
    1. Carithers HA. Cat-scratch disease: an overview based on a study of 1,200 patients. Am J Dis Child. 1985;139:1124–33. - PubMed
    1. Margileth AM. Antibiotic therapy for cat scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J. 1992;11:474–8. 10.1097/00006454-199206000-00010 - DOI - PubMed
    1. La Scola B, Raoult D. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J Clin Microbiol. 1999;37:1899–905. - PMC - PubMed
    1. Brenner SA, Rooney JA, Manzewitsch P, Regnery RL. Isolation of Bartonella (Rochalimaea) henselae: effects of methods of blood collection and handling. J Clin Microbiol. 1997;35:544–7. - PMC - PubMed

Publication types

MeSH terms